difference between cryptocurrency and blockchain Top

Huichuan Technology traded 2.46 million shares today, with a turnover of 151 million yuan. Huichuan Technology traded 2.46 million shares today, with a turnover of 151 million yuan, accounting for 10.48% of the total turnover of the day. The transaction price was 61.25 yuan, which was the same as the market closing price of 61.25 yuan.Xinwangda: The subsidiary and Xiamen Tungsten Xinneng signed the Framework Agreement on Strategic Cooperation for Solid-State Batteries. Xinwangda announced that the subsidiary Xinwangda Power and Xiamen Tungsten Xinneng signed the Framework Agreement on Strategic Cooperation for Solid-State Batteries, and the two sides will carry out extensive and in-depth cooperation on research and development, mass production and market development of a series of new energy battery materials for solid-state batteries around their respective development strategies. The cooperation contents include the development of cathode materials for solid-state batteries, the development of electrolytes and related materials for solid-state batteries, the cooperative development of solid-state batteries and industrial cooperation.Yuncong Technology: "The R&D team of large-scale model agent products is basically dissolved" is all false information. Yuncong Technology said on the interactive platform that the company's R&D team is stable at present, and a rigorous and meticulous hierarchical division of labor system has been established for the research and development of large-scale model related products. The configuration of R&D echelon will be flexibly adjusted according to the continuous evolution of large model technology and the changes of market demand of agent products. The statements of "the No.1 position of the big model algorithm" and "the R&D team of the big model agent product is basically dissolved" mentioned in the question are false information, and the company reserves the right to pursue legal responsibility for this. The company has been unswervingly promoting the research and product development of large-scale model and agent-related technologies.

Zhonggong Education: Director Yi Ziting resigned due to retirement. Zhonggong Education announced that the company's board of directors recently received a written resignation report from Director Yi Ziting. Yi Ziting applied to the company's board of directors for resignation due to retirement, and will not hold other positions in the company after resignation.Li Tie's case will be pronounced in the first instance tomorrow. The court has informed his defender of the well-known football player Li Tie, the former head coach of China National Men's Football Team (hereinafter referred to as "China Men's Football Team"), that the case will be pronounced in public by the Intermediate People's Court of Xianning City, Hubei Province tomorrow, that is, December 13, 2024, Beijing time. In the previous court hearing, although Li Tie said that he "pleaded guilty and repented", he did not "plead guilty and admit punishment". (Economic Observer)Yibin Paper: Terminate the issue of A shares to specific targets in 2022 and withdraw the application documents. Yibin Paper announced that the company held the 31st meeting of the 11th Board of Directors and the 22nd meeting of the 11th Board of Supervisors on December 12, 2024, and deliberated and passed the Proposal on Terminating the Issue of A shares to specific targets in 2022 and withdrawing the application documents. Considering the changes in market environment and policies, and considering the actual situation, the company decided to terminate the issuance of A shares to specific targets.

Ministry of Health of Gaza: Since October 7, 2023, 44,835 Palestinians have been killed and 106,356 injured in Israeli military attacks on the Gaza.Turkey says Ethiopia and Somalia will negotiate the Horn of Africa agreement.Tiankang Bio: Tiankang Bio (002100) announced on the evening of December 12 that Tiankang Bio (stock code: 874339), a holding subsidiary of the company, intends to apply for public offering of shares to unspecified qualified investors and listing on the Beijing Stock Exchange. As of the disclosure date of the announcement, Tiankang Bio's public offering of shares to unspecified qualified investors and listing on the North Stock Exchange are under counseling.